Abstract
The tuberous sclerosis complex (TSC) syndrome is associated with numerous cutaneous pathologies (notably on the face), epilepsy, intellectual disability and developmental retardation and, overall, high occurrence of benign tumors in several organs, like angiofibromas, giant cell astrocytomas, renal angiomyolipomas, and pulmonary lymphangioleiomyomatosis. TSC is caused by mutations of either of the hamartin or tuberin proteins that are mainly cytoplasmic. Some studies published in the 1980s reported that TSC is associated with radiosensitivity. However, its molecular basis in TSC cells is not documented enough. Here, we examined the functionality of the repair and signaling of radiation-induced DNA double-strand breaks (DSB) in fibroblasts derived from TSC patients. Quiescent TSC fibroblast cells elicited abnormally low rate of recognized DSB reflected by a low yield of nuclear foci formed by phosphorylated H2AX histones. Irradiated TSC cells also presented a delay in the nucleo-shuttling of the ATM kinase, potentially due to a specific binding of ATM to mutated TSC protein in cytoplasm. Lastly, TSC fibroblasts showed abnormally high MRE11 nuclease activity suggesting genomic instability. A combination of biphosphonates and statins complemented these impairments by facilitating the nucleoshuttling of ATM and increasing the yield of recognized DSB. Our results showed that TSC belongs to the group of syndromes associated with low but significant defect of DSB signaling and delay in the ATM nucleo-shuttling associated with radiosensitivity.
Similar content being viewed by others
References
Bourneville D-M (1880) Sclérose tubéreuse des circonvolution cérébrales: Idiotie et épilepsie hemiplégique. Arch Neurol 1:81–91
Baskin HJ Jr (2008) The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol 38(9):936–952. doi:10.1007/s00247-008-0832-y
Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL et al, Tuberous Sclerosis Complex Working Group to Update the Research P (2016) Advances and future directions for tuberous sclerosis complex research: recommendations from the 2015 strategic planning conference. Pediatr Neurol 60:1–12. doi:10.1016/j.pediatrneurol.2016.03.015
Henske EP, Jozwiak S, Kingswood JC, Sampson JR, Thiele EA (2016) Tuberous sclerosis complex. Nat Rev Dis Primers 2:16035. doi:10.1038/nrdp.2016.35
Napolioni V, Curatolo P (2008) Genetics and molecular biology of tuberous sclerosis complex. Curr Genomics 9(7):475–487. doi:10.2174/138920208786241243
van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277(5327):805–808
European Chromosome 16 Tuberous Sclerosis C (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75(7):1305–1315
Hoogeveen-Westerveld M, Ekong R, Povey S, Karbassi I, Batish SD, den Dunnen JT, van Eeghen A, Thiele E et al (2012) Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Hum Mutat 33(3):476–479. doi:10.1002/humu.22007
Hoogeveen-Westerveld M, Ekong R, Povey S, Mayer K, Lannoy N, Elmslie F, Bebin M, Dies K et al (2013) Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex. Hum Mutat 34(1):167–175. doi:10.1002/humu.22202
Hoogeveen-Westerveld M, Wentink M, van den Heuvel D, Mozaffari M, Ekong R, Povey S, den Dunnen JT, Metcalfe K et al (2011) Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with tuberous sclerosis complex. Hum Mutat 32(4):424–435. doi:10.1002/humu.21451
Qin J, Wang Z, Hoogeveen-Westerveld M, Shen G, Gong W, Nellist M, Xu W (2016) Structural basis of the interaction between tuberous sclerosis complex 1 (TSC1) and Tre2-Bub2-Cdc16 domain family member 7 (TBC1D7). J Biol Chem 291(16):8591–8601. doi:10.1074/jbc.M115.701870
Overwater IE, Swenker R, van der Ende EL, Hanemaayer KB, Hoogeveen-Westerveld M, van Eeghen AM, Lequin MH, van den Ouweland AM et al (2016) Genotype and brain pathology phenotype in children with tuberous sclerosis complex. Eur J Hum Genet. doi:10.1038/ejhg.2016.85
Jentarra GM, Rice SG, Olfers S, Saffen D, Narayanan V (2011) Evidence for population variation in TSC1 and TSC2 gene expression. BMC Med Genet 12:29. doi:10.1186/1471-2350-12-29
Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL et al (2010) ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107(9):4153–4158. doi:10.1073/pnas.0913860107
Bodgi L, Foray N (2016) The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model. Int J Radiat Biol 92:117–131
Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L et al (2016) Influence of nucleoshuttling of the ATM protein in the healthy tissues response to radiation therapy: toward a molecular classification of human radiosensitivity. Int J Radiat Oncol Biol Phys 94(3):450–460. doi:10.1016/j.ijrobp.2015.11.013
Rothkamm K, Lobrich M (2003) Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 100(9):5057–5062
Bodgi L, Granzotto A, Devic C, Vogin G, Lesne A, Bottollier-Depois JF, Victor JM, Maalouf M et al (2013) A single formula to describe radiation-induced protein relocalization: towards a mathematical definition of individual radiosensitivity. J Theor Biol 333:135–145
Joubert A, Zimmerman KM, Bencokova Z, Gastaldo J, Rénier W, Chavaudra N, Favaudon V, Arlett C et al (2008) DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity? Int J Radiat Biol 84(2):1–19
Ferlazzo ML, Foray N (2016) Huntington disease: a disease of DNA methylation or DNA breaks? Am J Pathol 186(7):1750–1753. doi:10.1016/j.ajpath.2016.05.001
Ferlazzo ML, Sonzogni L, Granzotto A, Bodgi L, Lartin O, Devic C, Vogin G, Pereira S et al (2014) Mutations of the Huntington's disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates. Mol Neurobiol 49:1200–1211. doi:10.1007/s12035-013-8591-7
Bencokova Z, Devic C, Ferlazzo ML, Granzotto A, Sonzogni L, Burlet SF, Viau M, Bodgi L, Bachelet JT, Combemale P, Balosso J, Foray N (in press) Radiobiological characterization of neurofibromatosis type I : The neurofibromin protein impacts on the ATM-dependent DNA damage repair and signaling pathway. Molecular neurobiology
Deschavanne PJ, Fertil B (1996) A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34(1):251–266
Paterson MC, Sell BM, Smith BP, Bech-Hansen NT (1982) Impaired colony-forming ability following gamma irradiation of skin fibroblasts from tuberous sclerosis patients. Radiat Res 90(2):260–270
Hayashi A, Yoshida Y, Tanaka H, Arima M, Ohno K (1985) Variable radiosensitivity in fibroblasts from patients with tuberous sclerosis. J Invest Dermatol 84(1):77–78
Scudiero DA, Moshell AN, Scarpinato RG, Meyer SA, Clatterbuck BE, Tarone RE, Robbins JH (1982) Lymphoblastoid lines and skin fibroblasts from patients with tuberous sclerosis are abnormally sensitive to ionizing radiation and to a radiomimetic chemical. J Invest Dermatol 78(3):234–238
Duchemann B, Wong S, Baruch-Hennequin V, Rivera S, Quero L, Hennequin C (2013) Hypersensitivity to radiation therapy in a patient with tuberous sclerosis: biological considerations about a clinical case. Cancer radiotherapie: journal de la Societe francaise de radiotherapie oncologique 17(1):50–53. doi:10.1016/j.canrad.2012.11.001
Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE et al (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med Off J Am Coll Med Genet 9(2):88–100. doi:10.1097/GIM.0b013e31803068c7
Foray N, Priestley A, Alsbeih G, Badie C, Capulas EP, Arlett CF, Malaise EP (1997) Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 72(3):271–283
Foray N, Fertil B, Alsbeih MG, Badie C, Chavaudra N, Iliakis G, Malaise EP (1996) Dose-rate effect on radiation-induced DNA double-strand breaks in the human fibroblast HF19 cell line. Int J Radiat Biol 69(2):241–249
Varela I, Pereira S, Ugalde AP, Navarro CL, Suarez MF, Cau P, Cadinanos J, Osorio FG et al (2008) Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med 14(7):767–772
Badie C, Iliakis G, Foray N, Alsbeih G, Cedervall B, Chavaudra N, Pantelias G, Arlett C et al (1995) Induction and rejoining of DNA double-strand breaks and interphase chromosome breaks after exposure to X rays in one normal and two hypersensitive human fibroblast cell lines. Radiat Res 144(1):26–35
Foray N, Marot D, Gabriel A, Randrianarison V, Carr AM, Perricaudet M, Ashworth A, Jeggo P (2003) A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J 22(11):2860–2871
Foray N, Bourguignon M, Hamada N (2016) Individual response to ionizing radiation. Mutat Res Rev 770:369–386
Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ (2001) ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276(45):42462–42467
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273(10):5858–5868
Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421(6922):499–506
Yoshida Y, Hayashi A, Arima M (1985) Rapid rejoining of X-ray-induced DNA single-strand breaks in tuberous sclerosis fibroblasts. Mutat Res 146(2):211–218
Matsumura H, Takimoto H, Shimada N, Hirata M, Ohnishi T, Hayakawa T (1998) Glioblastoma following radiotherapy in a patient with tuberous sclerosis. Neurol Med Chir 38(5):287–291
Curatolo P, Bjornvold M, Dill PE, Ferreira JC, Feucht M, Hertzberg C, Jansen A, Jozwiak S et al (2016) The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions. Drugs 76(5):551–565. doi:10.1007/s40265-016-0552-9
Curatolo P, Moavero R (2012) mTOR inhibitors in tuberous sclerosis complex. Curr Neuropharmacol 10(4):404–415. doi:10.2174/157015912804143595
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost MD, Kuperman R, Witt O, Kohrman MH et al (2016) Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study. PLoS One 11(6):e0158476. doi:10.1371/journal.pone.0158476
Acknowledgements
This work was supported by the Plan Cancer/AVIESAN grants, the Commissariat General à l’Investissement (Programmes Investissement d’avenir—projet INDIRA), the Association Pour la Recherche sur l’Ataxie-Telangiectasie (APRAT) and the Association Neurofibromatose et Recklinghausen (ANR).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ferlazzo, M.L., Bach-Tobdji, M.K.E., Djerad, A. et al. Radiobiological Characterization of Tuberous Sclerosis: a Delay in the Nucleo-Shuttling of ATM May Be Responsible for Radiosensitivity. Mol Neurobiol 55, 4973–4983 (2018). https://doi.org/10.1007/s12035-017-0648-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-017-0648-6